GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » Intermolecular Inc (NAS:IMI) » Definitions » Total Liabilities

Intermolecular (Intermolecular) Total Liabilities : $17.50 Mil (As of Jun. 2019)


View and export this data going back to 2011. Start your Free Trial

What is Intermolecular Total Liabilities?

Intermolecular's Total Liabilities for the quarter that ended in Jun. 2019 was $17.50 Mil.

Intermolecular's quarterly Total Liabilities increased from Dec. 2018 ($9.01 Mil) to Mar. 2019 ($17.58 Mil) but then declined from Mar. 2019 ($17.58 Mil) to Jun. 2019 ($17.50 Mil).

Intermolecular's annual Total Liabilities increased from Dec. 2016 ($8.17 Mil) to Dec. 2017 ($8.24 Mil) and increased from Dec. 2017 ($8.24 Mil) to Dec. 2018 ($9.01 Mil).


Intermolecular Total Liabilities Historical Data

The historical data trend for Intermolecular's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intermolecular Total Liabilities Chart

Intermolecular Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.17 13.58 8.17 8.24 9.01

Intermolecular Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.81 7.30 9.01 17.58 17.50

Intermolecular Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Intermolecular's Total Liabilities for the fiscal year that ended in Dec. 2018 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6.342+(0+8.8817841970013E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+2.667+0)
=9.01

Total Liabilities=Total Assets (A: Dec. 2018 )-Total Equity (A: Dec. 2018 )
=43.393-34.384
=9.01

Intermolecular's Total Liabilities for the quarter that ended in Jun. 2019 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=5.663+(11.832+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=17.50

Total Liabilities=Total Assets (Q: Jun. 2019 )-Total Equity (Q: Jun. 2019 )
=45.278-27.783
=17.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intermolecular Total Liabilities Related Terms

Thank you for viewing the detailed overview of Intermolecular's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Intermolecular (Intermolecular) Business Description

Traded in Other Exchanges
N/A
Address
3011 North First Street, San Jose, CA, USA, 95134
Intermolecular Inc operates in the technology sector based in the United States. It manufactures and sells support materials for the semiconductor industry. Its HPC platform, which consists of the Tempus processing tools, automated characterization methods and Informatics analysis software, is purpose-built for research and development ("R&D") using combinatorial process systems in concert with established CVD, physical vapor deposition ("PVD") and atomic layer deposition ("ALD") deposition methods. It caters to semiconductor device, semiconductor materials and equipment and clean energy market companies primarily in the Asia-Pacific region.
Executives
Raging Capital Management, Llc 10 percent owner TEN PRINCETON AVENUE, PO BOX 228, ROCKY HILL NJ 08553-0228
Christian Kramer director, officer: President and CEO 6 DAVIS AVE APT B22, RYE NY 10580
Irwin Federman 10 percent owner 2735 SAND HILL ROAD, MENLO PARK CA 94025
Kenneth H Traub director
William C Martin 10 percent owner C/O RAGING CAPITAL MANAGEMENT, LLC, TEN PRINCETON AVENUE, PO BOX 228, ROCKY HILL NJ 08553
Bill Roeschlein officer: Chief Financial Officer C/O SELECTICA, INC., 3 WEST PLUMERIA, SAN JOSE CA 95134
George Scalise director
Marvin D Burkett director C/O ENTEGRIS, INC., 129 CONCORD ROAD, BILLERICA MA 01821
Redpoint Ventures Ii, L.p. 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 290, MENLO PARK CA 94025
Redpoint Associates Ii, Llc 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 290, MENLO PARK CA 94025
Redpoint Ventures Ii, Llc 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 290, MENLO PARK CA 94025
Neil S Subin other: Former 10% Owner 2336 S.E. OCEAN BOULEVARD, #400, STUART FL 34996
Presidio Management Group Ix, L.l.c. 10 percent owner 2735 SAND HILL ROAD, MENLO PARK CA 94025
Steven M Krausz 10 percent owner 2735 SAND HILL ROAD, MENLO PARK CA 94025
U S Venture Partners Ix L P 10 percent owner 2735 SAND HILL RD, MENLO PARK CA 94025

Intermolecular (Intermolecular) Headlines

From GuruFocus

WeissLaw LLP Investigates Intermolecular, Inc. Acquisition

By PRNewswire PRNewswire 05-16-2019